Peter Eddershaw

2.1k total citations
30 papers, 1.5k citations indexed

About

Peter Eddershaw is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Peter Eddershaw has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Peter Eddershaw's work include Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (10 papers) and Computational Drug Discovery Methods (9 papers). Peter Eddershaw is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (10 papers) and Computational Drug Discovery Methods (9 papers). Peter Eddershaw collaborates with scholars based in United Kingdom, United States and Australia. Peter Eddershaw's co-authors include Michael H. Tarbit, Peter S. Goldfarb, Maurice Dickins, Alan Beresford, David F. Lewis, Martin K. Bayliss, Chris Luscombe, D. F. V. Lewis, Anne Hersey and Yuan H. Zhao and has published in prestigious journals such as Bioinformatics, Journal of Medicinal Chemistry and American Journal of Obstetrics and Gynecology.

In The Last Decade

Peter Eddershaw

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Eddershaw United Kingdom 18 639 525 464 357 292 30 1.5k
David J. Rance United Kingdom 15 834 1.3× 216 0.4× 636 1.4× 452 1.3× 178 0.6× 18 1.7k
Zhengyin Yan United States 26 587 0.9× 278 0.5× 803 1.7× 369 1.0× 296 1.0× 59 1.8k
Susanne Winiwarter Sweden 19 261 0.4× 482 0.9× 510 1.1× 439 1.2× 293 1.0× 40 1.6k
Claire Mackie Belgium 25 490 0.8× 421 0.8× 793 1.7× 394 1.1× 259 0.9× 49 2.0k
Geert Mannens Belgium 25 749 1.2× 153 0.3× 550 1.2× 472 1.3× 150 0.5× 59 2.1k
Matthew D. Troutman United States 21 532 0.8× 424 0.8× 880 1.9× 1.1k 3.0× 281 1.0× 30 2.4k
Abdul Mutlib United States 24 825 1.3× 264 0.5× 902 1.9× 339 0.9× 335 1.1× 61 2.5k
Regina W. Wang United States 22 1.1k 1.7× 241 0.5× 494 1.1× 646 1.8× 160 0.5× 32 1.9k
Tristan S. Maurer United States 29 998 1.6× 508 1.0× 908 2.0× 1.1k 3.1× 214 0.7× 64 2.9k
Natilie Hosea United States 16 549 0.9× 265 0.5× 439 0.9× 487 1.4× 127 0.4× 21 1.5k

Countries citing papers authored by Peter Eddershaw

Since Specialization
Citations

This map shows the geographic impact of Peter Eddershaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Eddershaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Eddershaw more than expected).

Fields of papers citing papers by Peter Eddershaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Eddershaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Eddershaw. The network helps show where Peter Eddershaw may publish in the future.

Co-authorship network of co-authors of Peter Eddershaw

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Eddershaw. A scholar is included among the top collaborators of Peter Eddershaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Eddershaw. Peter Eddershaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Sanjeev, James M. Reynolds, Yongkai Sun, et al.. (2022). Application of a high‐resolution in vitro human MDR1‐MDCK assay and in vivo studies in preclinical species to improve prediction of CNS drug penetration. Pharmacology Research & Perspectives. 10(1). e00932–e00932. 12 indexed citations
2.
Kemp, Matthew W., Masatoshi Saito, Augusto F. Schmidt, et al.. (2019). The duration of fetal antenatal steroid exposure determines the durability of preterm ovine lung maturation. American Journal of Obstetrics and Gynecology. 222(2). 183.e1–183.e9. 23 indexed citations
3.
Kemp, Matthew W., Masatoshi Saito, Haruo Usuda, et al.. (2018). The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy. American Journal of Obstetrics and Gynecology. 219(3). 301.e1–301.e16. 46 indexed citations
4.
5.
6.
Valkó, Klára, James Butler, & Peter Eddershaw. (2013). Predictive approaches to increase absorption of compounds during lead optimisation. Expert Opinion on Drug Discovery. 8(10). 1225–1238. 14 indexed citations
7.
Aljayyoussi, Ghaith, Glyn Taylor, Mathew W. Smith, et al.. (2013). Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: A study in ex vivo lung models using chemical inhibition and genetic knockout. Journal of Pharmaceutical Sciences. 102(9). 3382–3394. 28 indexed citations
8.
Lewis, D. F. V., et al.. (2010). An Evaluation of Ondansetron Binding Interactions with Human Cytochrome P450 Enzymes CYP3A4 and CYP2D6. Drug Metabolism Letters. 4(1). 25–30. 7 indexed citations
9.
Ward, Simon E., Peter Eddershaw, Laurie Gordon, et al.. (2008). Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands—Part II. Bioorganic & Medicinal Chemistry Letters. 19(2). 428–432. 7 indexed citations
10.
Thomas, David R., Sergio Melotto, Andrew D. Gribble, et al.. (2003). SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats. British Journal of Pharmacology. 139(4). 705–714. 101 indexed citations
11.
Lewis, D. F. V., Brian G. Lake, Stephen G. George, et al.. (1999). Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. Toxicology. 139(1-2). 53–79. 49 indexed citations
12.
Lewis, D. F. V., Maurice Dickins, Peter Eddershaw, Michael H. Tarbit, & Peter S. Goldfarb. (1999). Cytochrome P450 Substrate Specificities, Substrate Structural Templates and Enzyme Active Site Geometries. Drug metabolism and drug interactions. 15(1). 1–50. 59 indexed citations
13.
Segall, Matthew, M. C. Payne, S. W. Ellis, GT Tucker, & Peter Eddershaw. (1999). First principles investigation of singly reduced cytochrome P450. Xenobiotica. 29(6). 561–571. 8 indexed citations
14.
Dickins, Maurice, et al.. (1999). Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity. Toxicology. 133(1). 1–33. 46 indexed citations
15.
Lewis, David F., Maurice Dickins, Richard Weaver, et al.. (1998). Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily. Xenobiotica. 28(3). 235–268. 56 indexed citations
16.
Eddershaw, Peter, et al.. (1996). THE ALIPHATIC OXIDATION OF SALMETEROL TO α-HYDROXYSALMETEROL IN HUMAN LIVER MICROSOMES IS CATALYZED BY CYP3A. Drug Metabolism and Disposition. 24(5). 555–559.
17.
Lewis, D. F. V., Peter Eddershaw, Peter S. Goldfarb, & Michael H. Tarbit. (1996). Molecular modelling of CYP3A4 from an alignment with CYP102: Identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotica. 26(10). 1067–1086. 80 indexed citations
18.
Eddershaw, Peter, et al.. (1996). Absorption and disposition of ranitidine hydrochloride in rat and dog. Xenobiotica. 26(9). 947–956. 13 indexed citations
19.
Cannell, Richard J. P., Andrew R. Knaggs, Michael J. Dawson, et al.. (1995). Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.. Drug Metabolism and Disposition. 23(7). 724–729. 21 indexed citations
20.
Bowers, Gary D., et al.. (1994). Characterization of glucuronic acid conjugates of a novel angiotensin receptor antagonist. Rapid Communications in Mass Spectrometry. 8(2). 217–221. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David J. Rance Breakdown of academic impact, for papers by Zhengyin Yan Breakdown of academic impact, for papers by Susanne Winiwarter Breakdown of academic impact, for papers by Claire Mackie Breakdown of academic impact, for papers by Geert Mannens Breakdown of academic impact, for papers by Matthew D. Troutman Breakdown of academic impact, for papers by Abdul Mutlib Breakdown of academic impact, for papers by Regina W. Wang Breakdown of academic impact, for papers by Tristan S. Maurer Breakdown of academic impact, for papers by Natilie Hosea
Rankless by CCL
2026